CQDM’s funding program for Quantum Leap biopharmaceutical research helps Canadian SMEs and universities undertake innovative translational R&D projects in collaboration with large biopharmaceutical organizations. The chosen projects aim to develop cutting-edge technologies with a potentially significant impact on the R&D activities of CQDM biopharmaceutical members. Quantum Leap projects are undertaken in close collaboration and with expert support and funding from our pharmaceutical members.